Pharmidex attending FENS Neuroscience conference
June 23, 2018
Pharmidex will be attending this years FENS neuroscience conference, where the CNS team will be presenting a poster.
Pharmidex will presenting "Dopamine metabolism in striatum, and rearing behaviour, suggest different significance on the attenuation of nicotine-induced changes on total locomotor activity for Varenicline and Baclofen."
The Abstract number for our presentation is F18-2414ABSTRACT. For more information please come and find our presentation as stated below!
Session Name: C. DISORDERS OF THE NERVOUS SYSTEM - C.15.l Psychiatric disorders: Addiction and drugs of abuse - part II
Date: 8 July 2018
Session Time: 14:00 - 17:30
Poster Board Number: C169
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates. If you're attending, let’s connect and explore new opportunities together!
